Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

<p>Abstract</p> <p>Background</p> <p>Pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk of acquiring fungal infections. Antifungal prophylaxis shortly after transplantation is therefore indicated, but data for pediatric patient...

Full description

Bibliographic Details
Main Authors: Döring Michaela, Müller Carsten, Johann Pascal-David, Erbacher Annika, Kimmig Astrid, Schwarze Carl-Philipp, Lang Peter, Handgretinger Rupert, Müller Ingo
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Infectious Diseases
Subjects:
Posaconazole
Posaconazole trough levels
Pediatric patients
Antifungal prophylaxis
Stem cell transplantation
Online Access:http://www.biomedcentral.com/1471-2334/12/263

Internet

http://www.biomedcentral.com/1471-2334/12/263

Similar Items